We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
-8.41%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$22.8B
AUM Growth
-$4.41B
(-16%)
Cap. Flow
-$1.27B
Cap. Flow
% of AUM
-5.6%
Top 10 Holdings %
Top 10 Hldgs %
36.84%
Holding
614
New
135
Increased
158
Reduced
239
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$187M |
| 3 |
Netflix
NFLX
|
+$179M |
| 4 |
Starbucks
SBUX
|
+$114M |
| 5 |
Novartis
NVS
|
+$92.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$260M |
| 2 |
Microsoft
MSFT
|
+$208M |
| 3 |
Salesforce
CRM
|
+$171M |
| 4 |
Dollar Tree
DLTR
|
+$171M |
| 5 |
Adobe
ADBE
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.16% |
| 2 | Healthcare | 22.78% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Communication Services | 9.78% |
| 5 | Financials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Wells Fargo
WFC
$261B
| $903K | ﹤0.01% |
31,474
-726
| -2% | -$30.9K |
|
|
XLRN
327
DELISTED
Acceleron Pharma
XLRN
| $899K | ﹤0.01% |
+10,000
| New | +$777K |
|
328
Chevron
CVX
$392B
| $895K | ﹤0.01% |
12,356
-307
| -2% | -$30.3K |
|
329
Zoom
ZM
$28.2B
| $888K | ﹤0.01% |
+6,077
| New | +$600K |
|
330
General Dynamics
GD
$104B
| $832K | ﹤0.01% |
6,290
-144
| -2% | -$23.9K |
|
331
Lamar Advertising Co
LAMR
$16.2B
| $823K | ﹤0.01% |
16,046
-374
| -2% | -$30.1K |
|
332
Aurinia Pharmaceuticals
AUPH
$1.91B
| $813K | ﹤0.01% |
56,000
+9,000
| +19% | +$159K |
|
333
ConocoPhillips
COP
$147B
| $805K | ﹤0.01% |
26,121
-606
| -2% | -$30.8K |
|
334
Philip Morris
PM
$297B
| $776K | ﹤0.01% |
+10,631
| New | +$875K |
|
335
Afya
AFYA
$1.31B
| $758K | ﹤0.01% |
39,753
+3,000
| +8% | +$74.4K |
|
336
Twist Bioscience
TWST
$5.7B
| $734K | ﹤0.01% |
+24,000
| New | +$645K |
|
337
OraSure Technologies
OSUR
$279M
| $726K | ﹤0.01% |
+67,449
| New | +$483K |
|
338
Blackstone Mortgage Trust
BXMT
$2.45B
| $723K | ﹤0.01% |
38,803
-895
| -2% | -$30.4K |
|
339
Cheniere Energy
CQP
$31.9B
| $713K | ﹤0.01% |
26,416
-612
| -2% | -$20.9K |
|
340
Zymeworks
ZYME
$1.61B
| $709K | ﹤0.01% |
20,000
-2,000
| -9% | -$81.9K |
|
341
STAG Industrial
STAG
$7.38B
| $708K | ﹤0.01% |
+31,442
| New | +$915K |
|
|
MRTX
342
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $692K | ﹤0.01% |
9,000
-3,500
| -28% | -$314K |
|
343
Iovance Biotherapeutics
IOVA
$1.82B
| $689K | ﹤0.01% |
23,000
-22,000
| -49% | -$583K |
|
|
IMMU
344
DELISTED
Immunomedics Inc
IMMU
| $674K | ﹤0.01% |
50,000
+4,000
| +9% | +$67.3K |
|
345
Neurocrine Biosciences
NBIX
$16.8B
| $673K | ﹤0.01% |
7,775
-30,550
| -80% | -$2.99M |
|
|
KYNB
346
Kyntra Bio
KYNB
$27.2M
| $626K | ﹤0.01% |
720
-200
| -22% | -$199K |
|
347
Chewy
CHWY
$9.25B
| $622K | ﹤0.01% |
+16,594
| New | +$487K |
|
348
Fate Therapeutics
FATE
$286M
| $622K | ﹤0.01% |
28,000
-20,000
| -42% | -$506K |
|
349
Mesa Laboratories
MLAB
$564M
| $609K | ﹤0.01% |
2,694
+1,029
| +62% | +$254K |
|
350
Prologis
PLD
$135B
| $587K | ﹤0.01% |
7,305
| – | – |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q1 2020 Portfolio in Review
As of Q1 2020, Fred Alger Management held 614 positions worth $22.8B, down 16% from $27.2B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Fred Alger Management withdrew a net $1.27B in Q1 2020, closing 65 positions and reducing 239 holdings. Its most notable exit was Dermira, Inc., an estimated $46.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Fred Alger Management opened a new position in AtriCure worth $42.4M.
- Fred Alger Management's largest Q1 2020 buy was AtriCure: 1,263,408 shares worth $42.4M.
- Fred Alger Management added most to NVIDIA in Q1 2020, an estimated $190M increase.
- Fred Alger Management's biggest Q1 2020 reduction was Abbott, cutting an estimated $260M.
- Fred Alger Management fully exited Dermira, Inc. in Q1 2020, selling an estimated $46.3M.
- Fred Alger Management's ten largest holdings make up 37% of its $22.8B portfolio in Q1 2020.
- Fred Alger Management opened 135 new positions and closed 65 in Q1 2020.
- Fred Alger Management's portfolio value fell 16% quarter-over-quarter to $22.8B.
Based on Fred Alger Management's 13F filing for Q1 2020, filed 15 May 2020.